Cargando…
The Effect of Glutamatergic Modulators on Extracellular Glutamate: How Does this Information Contribute to the Discovery of Novel Antidepressants?
BACKGROUND: In the search for new antidepressants, clinical researchers have been using drugs that simultaneously modulate multiple targets. During preclinical and clinical trials, the glutamatergic modulators riluzole and ketamine have received particular attention. Glutamatergic agents have a modu...
Autor principal: | Frizzo, Marcos Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911922/ https://www.ncbi.nlm.nih.gov/pubmed/31871505 http://dx.doi.org/10.1016/j.curtheres.2019.100566 |
Ejemplares similares
-
Can a Selective Serotonin Reuptake Inhibitor Act as a Glutamatergic Modulator?
por: Frizzo, Marcos Emilio
Publicado: (2017) -
Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants
por: Chaki, Shigeyuki, et al.
Publicado: (2015) -
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
por: Kadriu, Bashkim, et al.
Publicado: (2018) -
Glutamate receptors and glutamatergic signalling in the peripheral nerves
por: Chen, Ting-Jiun, et al.
Publicado: (2019) -
Rapid-acting antidepressants targeting modulation of the glutamatergic system: clinical and preclinical evidence and mechanisms
por: Wang, Shikai, et al.
Publicado: (2022)